article thumbnail

Key Trends Drug Developers Need to Know to Succeed

PPD

As the pharmaceutical industry continues to evolve, drug developers encounter new challenges and opportunities in their pursuit of innovation. In response, the PPD clinical research business of Thermo Fisher Scientific conducted its third global survey of 150 drug developers to capture a comprehensive view of these evolving trends.

article thumbnail

The Real Cost of Complexity: What Every Drug Developer Needs to Know

PPD

Our annual look at the state of the drug development industry highlights a dual set of challenges complicating progress. Rising costs have become a persistent challenge for drug developers, driven by a combination of internal and external pressures that have intensified in recent years.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Report Reveals Trends, Opportunities in Drug Development

PPD

As the clinical trial landscape evolves, drug developers are faced with novel challenges and changes in study recruitment, trial size and structure, and more. The adoption of new innovations, strategies and technologies offers opportunities to address persistent challenges and develop suitable approaches for the future.

article thumbnail

The Essential Roadmap to Drug Development for Bioanalytical Success

Fierce BioTech

The Essential Roadmap to Drug Development for Bioanalytical Success Discover the 3 pillars of successful PK testing and conquer bioanalytical challenges with this whitepaper’s insights. Download now.

article thumbnail

From Cloud to Local: Effortlessly Import Azure SQL Databases

Perficient: Drug Development

Download SqlPackage Navigate to the SqlPackage download page: SqlPackage Download. Ensure you download the.NET 6 version of the tool, as the.NET Framework version may have issues processing databases with very large tables. NET 6)” header to download and extract the tool.

article thumbnail

Increasing the probability of technical success in drug development using AI and patient heterogeneity

Predictive Oncology

By combining these two assets, this offering represents an opportunity to de-risk drug discovery and accelerate pipeline development. Complete the form below to download the white paper.

article thumbnail

Survey Uncovers Global Challenges and Opportunities in Drug Development

PPD

The PPD clinical research business of Thermo Fisher Scientific has surveyed more than 150 drug developers around the globe to gather annual data on trends in pharmaceutical research and development. Applying artificial intelligence (AI) to drug development (e.g., mRNA, drug discovery platforms) ranked as the No.